The simulation administers repeated opioid doses to a virtual mu-opioid receptor population, showing the dose-response curve shift rightward as tolerance develops, then removes the drug to reveal a rebound withdrawal spike in neuronal activity.
Use the dosing frequency and dose-size sliders to build tolerance over simulated days, then hit the stop-dosing control to watch receptor signaling rebound into a withdrawal state.
Dose size and dosing frequency sliders, plus a stop-dosing withdrawal trigger
Tolerance to opioid pain relief typically develops faster than tolerance to the suppression of breathing, which is a major reason why relapse after a period of abstinence carries such a high overdose risk.
The simulation administers repeated opioid doses to a virtual mu-opioid receptor population, showing the dose-response curve shift rightward as tolerance develops, then removes the drug to reveal a rebound withdrawal spike in neuronal activity.
The simulation administers repeated opioid doses to a virtual mu-opioid receptor population, showing the dose-response curve shift rightward as tolerance develops, then removes the drug to reveal a rebound withdrawal spike in neuronal activity.
Use the dosing frequency and dose-size sliders to build tolerance over simulated days, then hit the stop-dosing control to watch receptor signaling rebound into a withdrawal state.
Tolerance to opioid pain relief typically develops faster than tolerance to the suppression of breathing, which is a major reason why relapse after a period of abstinence carries such a high overdose risk.